![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Combination of Elbasvir and Grazoprevir ± RBV Is Highly
Effective for the Treatment of GT1a-Infected Patients
|
|
|
Reported by Jules Levin
Presented at
AASLD - The Liver Meeting 2015®;
November 13-17, 2015;
San Francisco, CA, USA.
Thompson A1; Zeuzem S2; Rockstroh J3; Kwo P4; Roth D5; Lawitz E6; Sulkowski M7; Forns X8; Wahl J9; Nguyen B-Y9; Barr E9; Howe A9*; Miller M9; Hwang P9; Robertson MN9
1University of Melbourne, Department of Medicine, Melbourne, Australia; 2Goethe University Hospital, Frankfurt, Germany; 3Bonn University Hospital, Bonn, Germany; 4Indiana University School of Medicine, Indianapolis, IN, USA; 5University of Miami Miller School of Medicine, Miami, FL, USA; 6The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA; 7Johns Hopkins University School of Medicine, Baltimore, MD, USA; 8Liver Unit, Hospital Clinic, IDIBAPS and CIBEREHD, Barcelona, Spain; 9Merck & Co., Inc., Kenilworth, NJ, USA
![AASLD1.gif](../images/111715/111715-4/AASLD1.gif)
![AASLD2.gif](../images/111715/111715-4/AASLD2.gif)
![AASLD3.gif](../images/111715/111715-4/AASLD3.gif)
![AASLD4.gif](../images/111715/111715-4/AASLD4.gif)
![AASLD5.gif](../images/111715/111715-4/AASLD5.gif)
![AASLD6.gif](../images/111715/111715-4/AASLD6.gif)
![AASLD7.gif](../images/111715/111715-4/AASLD7.gif)
![AASLD8.gif](../images/111715/111715-4/AASLD8.gif)
![AASLD9.gif](../images/111715/111715-4/AASLD9.gif)
![AASLD10.gif](../images/111715/111715-4/AASLD10.gif)
![AASLD11.gif](../images/111715/111715-4/AASLD11.gif)
![AASLD12.gif](../images/111715/111715-4/AASLD12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|